EpiTrax 1.5 offers more in–depth reporting functionality and overall improvements to its seizure tracking capabilities
Los Angeles – November 1, 2007 – NeoMed Software LLC announced today that it has launched an upgrade to its seizure diary software, EpiTrax. The new version, which comes at the beginning of Epilepsy Awareness Month, provides more in–depth reporting and analysis functionality to users of the software, improving its overall seizure tracking capabilities.
“Since the launch of EpiTrax, we’ve collected extensive feedback from trial users and customers alike,” explains Eric Schumacher, CEO of NeoMed Software. “As a result of that feedback, we’ve focused a lot of energy and resources on creating more powerful reporting and analysis tools. EpiTrax 1.5 is the result of our efforts.”
EpiTrax allows users to record comprehensive details about their seizures, their daily events, their diet, their moods and more. However, unlike any other seizure diary, EpiTrax allows individuals to run reports on, and analyze, the information they record in order to gain a much deeper understanding of their seizures and the root causes of those seizures. The EpiTrax reports can then be printed and shared with physicians as a means of improving patient–doctor communication and developing more appropriate seizure treatments.
EpiTrax 1.5 extends its reporting functionality with three new reports:
A new Trend Report that visually displays total seizure activity over time, as well as the activity of individual seizure types over time. This is especially useful for individuals affected by more than one seizure type.
A new Monthly Report that displays seizures by month, by day and by hour, and compares them to medication types and patterns. This report enables patients and doctors to instantly recognize which anti–epilepsy drugs (AEDs), or combination of drugs, are working and which are not.
A new Questions for Doctor Report that enables users to print out all questions they have for their physician and take them to their doctor. This greatly simplifies patient–doctor communications.
In addition to the new reports, NeoMed Software has improved three other EpiTrax reports, including:
The Medication Report, which now contains more statistical information in an easy–to–read, printable format.
The Day Time and Weekday Reports, which are now displayed side–by–side, making it easier for patients and doctors to analyze when seizures are occurring during the day and during the week.
The Potential Trigger List, which displays in easy–to–read, line item format the probability that certain events in an individual’s life are triggering seizures.
Finally, NeoMed has restructured the analysis features of EpiTrax for greater flexibility. Now users have the option of drilling further into their recorded information in order to identify patterns that may not be apparent in the standard reports. Coupled with the new reporting functionality, these flexible analysis features give patients a greater ability to track their seizures.
EpiTrax 1.5 is available for Microsoft Windows only and can be purchased from the NeoMed web site (www.neomedsoft.com) for $49.99. All current customers who have been working with EpiTrax 1.0 will receive the new version for free.
Visit NeoMed Software at the upcoming Epilepsy Brain Storm Summit. The summit, which will present the latest in epilepsy research, treatment and advocacy, will take place on November 3rd at the Cathedral Plaza in downtown Los Angeles.
About Epilepsy
When a person has two or more unprovoked seizures, they have epilepsy. According to the International League against Epilepsy, there are two main types of seizures – partial or generalized – and more than 25 recognizable syndromes affecting three million people in the U.S. and 40–50 million people worldwide. This year, another 200,000 people in the United States will be diagnosed with the disease. To date, there is no known cure.
About NeoMed Software
NeoMed Software LLC provides seizure diary software to improve seizure tracking for countless people directly and indirectly affected by epilepsy. NeoMed launched its advanced seizure diary software, EpiTrax, in April 2007. The company’s executive offices are located in Los Angeles, CA. Its development studio is based in Munich, Germany. More information about the company and its downloadable product EpiTrax can be found at www.neomedsoft.com.